(Q58557866)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

title

Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Giacomo Emmi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Florenzo Iannone

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

3

Luca Cantarini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

2

Vincenzo Venerito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

author name string

Domenico Prisco

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

language of work or name

English

0 references

publication date

25 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

Internal and emergency medicine

30 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

719-722

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

30 April 2020

cites work

1 reference

12 December 2020

Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet's disease: an international cohort study of 110 patients. One-year follow-up data

1 reference

12 December 2020

Behçet's syndrome pathophysiology and potential therapeutic targets

1 reference

12 December 2020

Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease

1 reference

12 December 2020

Progress in biosimilar monoclonal antibody development: the infliximab biosimilar CT-P13 in the treatment of rheumatic diseases

1 reference

12 December 2020

Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease

1 reference

12 December 2020

Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study

1 reference

12 December 2020

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.

1 reference

12 December 2020

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

1 reference

12 December 2020

Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.

1 reference

12 December 2020

Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease

1 reference

12 December 2020

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

1 reference

12 December 2020

Behçet syndrome: a contemporary view.

1 reference

12 December 2020

Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator

1 reference

12 December 2020

10.1007/S11739-018-1970-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361849%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference